Recruiting studies: Adenocarcinoma Of The Duodenum

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Phase 2 · 22 location(s) · UNICANCER · NCT06333314 Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Inc
Phase 4 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07262957 Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Phase 1/Phase 2 · 1 location(s) · University Hospital, Lille · NCT05116072 Outcomes After Laparoscopic Versus Open Pancreaticoduodenectomy
NA · 1 location(s) · Minia University · NCT07328607 Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metast
Phase 2 · 1 location(s) · Yale University · NCT07282912

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.